Skip to Content
Emeritus Professor of Internal Medicine
- Hematology, Oncology and Blood and Marrow Transplantation
BS, Biochemistry, University of IllinoisMD, Rush Medical College, Rush UniversityPhD, Pharmacology, Graduate College, Rush University
Residency, University of ChicagoFellowship, Hematology/Oncology, University of Chicago
Interdisciplinary Graduate Program in Molecular and Cellular BiologyInterdisciplinary Graduate Program in Translational BiomedicineMedical Scientist Training Program
Dr. Hohl's research interests focus on understanding the interactions between mevalonic acid and cholesterol biosynthesis and the proliferation of acute myeloid leukemia cells. These studies investigate the relative affinities of various growth regulating proteins, such as RAS and KREV1, for the isoprene intermediates of the mevalonic acid to cholesterol biosynthetic pathway. His clinical interests involve evaluation of the potential role for pharmacologic inhibitors of this biosynthetic pathway in the treatment of various hematologic malignancies and solid tumors. Additionally, he has continued interest in studying how various erythrocyte enzymothathies predispose the human red blood cell to drug-induced oxidative damage.
Date Last Modified: 10/09/2015 -
Copyright © 2015 The University of Iowa. All Rights Reserved.